Evidence map›Paper›PMID 26297556›Full record

ArticleBrain : a journal of neurology2015

Closing the tau loop: the missing tau mutation.

Allan McCarthy, Roisin Lonergan, Diana A Olszewska, Sean O'Dowd, Gemma Cummins, Brian Magennis, Emer M Fallon, Niall Pender, Edward D Huey, Stephanie Cosentino and 11 more

Open access · bronzeAbstract readCase Reports
In one paragraph

Article in Brain : a journal of neurology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 41 citations in OpenAlex.

  1. In vivoNeurology · 2018
    Trial
  2. Review
  3. Review
  4. Prion-like strain effects in tauopathies.Cell and tissue research · 2023
    Review
  5. Review
  6. Review
  7. Tau and MAPT genetics in tauopathies and synucleinopathies.Parkinsonism & related disorders · 2021
    Review
  8. Article
  9. Review
  10. Small molecule targeting of RNA structures in neurological disorders.Annals of the New York Academy of Sciences · 2020
    Review
  11. Review
  12. Review
  13. Article
  14. Cognitive Indicators of Preclinical Behavioral Variant Frontotemporal Dementia in MAPT Carriers.Journal of the International Neuropsychological Society : JINS · 2019
    Article
  15. Rates of lobar atrophy in asymptomaticAlzheimer's & dementia (New York, N. Y.) · 2019
    Article
  16. Article
  17. Article
  18. Psychiatric symptoms in preclinical behavioural-variant frontotemporal dementia inJournal of neurology, neurosurgery, and psychiatry · 2018
    Article
  19. Review
  20. Amyloidogenesis of Tau protein.Protein science : a publication of the Protein Society · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 7 institutions in 3 countries.

Allan McCarthy1 The Dublin Neurological Institute at the Mater Misericordiae University Hospital, 57 Eccles Street, Dublin 7, Ireland.
Roisin Lonergan1 The Dublin Neurological Institute at the Mater Misericordiae University Hospital, 57 Eccles Street, Dublin 7, Ireland.
Diana A Olszewska1 The Dublin Neurological Institute at the Mater Misericordiae University Hospital, 57 Eccles Street, Dublin 7, Ireland.
Sean O'Dowd1 The Dublin Neurological Institute at the Mater Misericordiae University Hospital, 57 Eccles Street, Dublin 7, Ireland.
Gemma Cummins2 Department of Clinical Neuroscience, Centre for Brain Repair, Forvie Site, Robinson Way, Cambridge, CB2 0PY, UK.
Brian Magennis1 The Dublin Neurological Institute at the Mater Misericordiae University Hospital, 57 Eccles Street, Dublin 7, Ireland.
Emer M Fallon1 The Dublin Neurological Institute at the Mater Misericordiae University Hospital, 57 Eccles Street, Dublin 7, Ireland.
Niall Pender3 Department of Psychology, Beaumont Hospital, Beaumont Rd, Dublin 9, Ireland, Department of Psychology, Royal College of Surgeons in Ireland.
Edward D Huey4 Departments of Psychiatry and Neurology, College of Physicians and Surgeons, University Medical Centre, 630 West 168th Street, New York, NY 10032, USA.
Stephanie Cosentino5 Cognitive Neuroscience Section, Department of Neurology, Columbia University Medical Centre, 630 West 168th Street, New York, NY 10032, USA.
Killian O'Rourke1 The Dublin Neurological Institute at the Mater Misericordiae University Hospital, 57 Eccles Street, Dublin 7, Ireland.
Brendan D Kelly6 Department of Psychiatry, Mater Misericordiae University Hospital, 63 Eccles Street, Dublin 7, Ireland.
Martin O'Connell7 Department of Radiology, Mater Misericordiae University Hospital, North Circular Road, Dublin 7, Ireland.
Isabelle Delon8 Medical Genetics Service, Cambridge University Hospital NHS Foundation Trust, Addenbrooke's Treatment Centre, Hills Road, Cambridge, CB2 0QQ, UK.
Michael Farrell9 Department of Neuropathology, Beaumont Hospital, Beaumont Road, Dublin, Ireland.
Maria Grazia Spillantini10 Department of Clinical Neurosciences, Clifford Allbutt Building, University of Cambridge, Cambridge, CB2 0AH, UK.
Lewis P Rowland11 The Neurological Institute, Columbia University, 710 West 168th Street, New York, NY 10032-3784, USA.
Stanley Fahn11 The Neurological Institute, Columbia University, 710 West 168th Street, New York, NY 10032-3784, USA.
Peter Craig12 Eli Lilly, Erl Wood Manor, Windlesham, Surrey, GU20 6PH, UK.
Michael Hutton12 Eli Lilly, Erl Wood Manor, Windlesham, Surrey, GU20 6PH, UK.
Tim Lynch1 The Dublin Neurological Institute at the Mater Misericordiae University Hospital, 57 Eccles Street, Dublin 7, Ireland tlynch@dni.ie.
Mater Misericordiae University Hospital · IEEli Lilly (United Kingdom) · GBThe Neurological Institute · USUniversity of Cambridge · GBBeaumont Hospital · IEColumbia University Irving Medical Center · USRoyal College of Surgeons in Ireland · IE

Funding

Examination of the earliest symptoms and biomarkers of FTLD MAPT carriersR01NS076837 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI COSENTINO, STEPHANIE ANN, HUEY, EDWARD D · 2012 to 2016
$2.5M
Medical Research Council G0301152NINDS NIH HHS R01 NS076837NINDS NIH HHS R0S NS076837-02
6 · The paper itself

Abstract

Frontotemporal lobar degeneration comprises a group of disorders characterized by behavioural, executive, language impairment and sometimes features of parkinsonism and motor neuron disease. In 1994 we described an Irish-American family with frontotemporal dementia linked to chromosome 17 associated with extensive tau pathology. We named this disinhibition-dementia-parkinsonism-amyotrophy complex. We subsequently identified mutations in the MAPT gene. Eleven MAPT gene splice site stem loop mutations were identified over time except for 5' splice site of exon 10. We recently identified another Irish family with autosomal dominant early amnesia and behavioural change or parkinsonism associated with the 'missing' +15 mutation at the intronic boundary of exon 10. We performed a clinical, neuropsychological and neuroimaging study on the proband and four siblings, including two affected siblings. We sequenced MAPT and performed segregation analysis. We looked for a biological effect of the tau variant by performing real-time polymerase chain reaction analysis of RNA extracted from human embryonic kidney cells transfected with exon trapping constructs. We found a c.915+15A>C exon 10/intron 10 stem loop mutation in all affected subjects but not in the unaffected. The c.915+15A>C variant caused a shift in tau splicing pattern to a predominantly exon 10+ pattern presumably resulting in predominant 4 repeat tau and little 3 repeat tau. This strongly suggests that the c.915+15A>C variant is a mutation and that it causes frontotemporal dementia linked to chromosome 17 in this pedigree by shifting tau transcription and translation to +4 repeat tau. Tau (MAPT) screening should be considered in families where amnesia or atypical parkinsonism coexists with behavioural disturbance early in the disease process. We describe the final missing stem loop tau mutation predicted 15 years ago. Mutations have now been identified at all predicted sites within the 'stem' when the stem-loop model was first proposed and no mutations have been found within the 'loop' region as expected. Therefore we 'close the tau loop' having 'opened the loop' 21 years ago.

Indexed as

BrainFamily HealthFluorodeoxyglucose F18Frontotemporal DementiaHumansMagnetic Resonance ImagingMaleMiddle AgedMutation, MissensePositron-Emission Tomographytau ProteinsFluorodeoxyglucose F18tau ProteinsdementiafrontotemporalFTDP-17MAPTstem loop

Identifiers

PMID26297556
PMCPMC5006396
OpenAlexW1926945198

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.